echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Pyrazinamide tablets, a wholly-owned subsidiary of Baiyunshan, passed the consistency evaluation of generic drugs

    Pyrazinamide tablets, a wholly-owned subsidiary of Baiyunshan, passed the consistency evaluation of generic drugs

    • Last Update: 2021-10-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On September 27, Baiyunshan issued an announcement stating that its wholly-owned subsidiary Mingxing Pharmaceutical had received the "Notice of Approval of Drug Supplement Application" issued by the State Food and Drug Administration on September 26.


    Mingxing Pharmaceutical’s pyrazinamide tablets were officially launched in China in 1982.


    Pyrazinamide tablets are anti-tuberculosis drugs and are used in combination with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol) to treat tuberculosis


    At present, the manufacturers of pyrazinamide tablets listed in China also include Shenyang Hongqi Pharmaceutical Co.


    As of the date of this announcement, Mingxing Pharmaceutical has invested approximately RMB 6.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.